Central African Republic vs Sao Tome and Principe: The number of people with susceptibility test result for rifampicin
Central African Republic
9.75
in 2021
Sao Tome and Principe
0
in 2021
Central African Republic rank
139th
Sao Tome and Principe rank
142nd
The number of people with susceptibility test result for rifampicin over time
- Central African Republic
- Sao Tome and Principe
How they compare
Central African Republic currently reports 9.75 against 0 in Sao Tome and Principe, a difference of 9.75.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Sao Tome and Principe ahead.
Central African Republic ranks 139th and Sao Tome and Principe ranks 142nd of 146 countries.
Across the 2 decades both report, Central African Republic averaged higher in 1 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | Central African Republic | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.64 | 20.76 | 19.12 | Sao Tome and Principe |
| 2020s | 10.12 | 1.04 | 9.08 | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or Sao Tome and Principe?
- Central African Republic, at 9.75 against 0 in Sao Tome and Principe as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and Sao Tome and Principe?
- 9.75, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Sao Tome and Principe?
- 5 years are reported by both, from 2017 to 2021.
- How do Central African Republic and Sao Tome and Principe rank globally for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 139th and Sao Tome and Principe ranks 142nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.